HOXA9 and acute myeloid leukemia: Similar approaches may be proposed against miRNAs or LncRNAs that are known to control HOXA9/PBX/MEIS expression in AML (such as miR-196b [306,307], miR-181 [248], let7c [307], miR-495 [308], HOTTIP [309]) or to control MLL and epigenetic drivers (such as miR-29b [310] and miR-9 [311]).